Document Detail

Nitroglycerin intravenous infusion.
MedLine Citation:
PMID:  6800751     Owner:  NLM     Status:  MEDLINE    
The treatment of various cardiovascular problems with intravenous nitroglycerin is widely practiced though unapproved. The uses of iv nitroglycerin include improvement of the hemodynamics of left ventricular failure and cardiogenic shock associated with infarction, control of hypertension during coronary artery surgery, and possibly, reduction of acute myocardial infarct size. The popularity of this treatment in the absence of an FDA-approved commercial product has forced some hospitals to prepare the drug extemporaneously, and the advantages and disadvantages of preparation and storage techniques are presented.
G T Elliott; S L Quinn
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug intelligence & clinical pharmacy     Volume:  16     ISSN:  0012-6578     ISO Abbreviation:  Drug Intell Clin Pharm     Publication Date:  1982 Mar 
Date Detail:
Created Date:  1982-05-21     Completed Date:  1982-05-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0212457     Medline TA:  Drug Intell Clin Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  211-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Stability
Hemodynamics / drug effects
Infusions, Parenteral
Myocardial Infarction / drug therapy,  physiopathology
Nitroglycerin / administration & dosage*,  pharmacology
Reg. No./Substance:
0/Solutions; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone scintigraphy for the detection and follow-up of hypertrophic osteoarthropathy.
Next Document:  Application of cost-benefit and cost-effectiveness analysis to clinical practice.